Cargando…
The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes
BACKGROUND: Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes and can exist with or without neuropathic pain. We were interested in how neuropathic pain impairs the quality of life in diabetic patients and what is the role of comorbidities in this condition. METHODS:...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264315/ https://www.ncbi.nlm.nih.gov/pubmed/25468384 http://dx.doi.org/10.1186/s12955-014-0171-7 |
_version_ | 1782348717829914624 |
---|---|
author | Dermanovic Dobrota, Vesna Hrabac, Pero Skegro, Dinko Smiljanic, Ranko Dobrota, Savko Prkacin, Ingrid Brkljacic, Neva Peros, Kristijan Tomic, Martina Lukinovic-Skudar, Vesna Basic Kes, Vanja |
author_facet | Dermanovic Dobrota, Vesna Hrabac, Pero Skegro, Dinko Smiljanic, Ranko Dobrota, Savko Prkacin, Ingrid Brkljacic, Neva Peros, Kristijan Tomic, Martina Lukinovic-Skudar, Vesna Basic Kes, Vanja |
author_sort | Dermanovic Dobrota, Vesna |
collection | PubMed |
description | BACKGROUND: Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes and can exist with or without neuropathic pain. We were interested in how neuropathic pain impairs the quality of life in diabetic patients and what is the role of comorbidities in this condition. METHODS: The study included 80 patients with painful DPN (group “P”) and 80 patients with DPN, but without neuropathic pain (group “D”). Visual analogue scale (VAS) and Leeds assessment of neuropathic symptoms and signs (LANSS) pain scale were used for assessment of neuropathic pain, SF-36 standardized questionnaire for assessment of the quality of life and BDI questionnaire for assessment of depression. RESULTS: Subjects in group P had statistically significantly lower values compared to group D in all 8 dimensions and both summary values of the SF-36 scale. We ascribe the extremely low results of all parameters of SF-36 scale in group P to painful diabetic polyneuropathy with its complications. The patients in group D showed higher average values in all dimension compared to group P, but also somewhat higher quality of life compared to general population of Croatia in 4 of 8 dimensions, namely vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH), which was unexpected result. Clinically, the most pronounced differences between two groups were noted in sleeping disorders and problems regarding micturition and defecation , which were significantly more expressed in group P. The similar situation was with walking distance and color-doppler sonography of carotid arteries, which were significantly worse in group P. Consequently, subjects in group P were more medicated than the patients in group D, particularly with tramadol, antiepileptics and antidepressants. CONCLUSION: Painful DPN is a major factor that influences various aspects of quality of life in diabetic patients. Additionally, this study gives an overview of diabetic population in the Republic of Croatia, information that could prove useful in future studies. |
format | Online Article Text |
id | pubmed-4264315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42643152014-12-13 The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes Dermanovic Dobrota, Vesna Hrabac, Pero Skegro, Dinko Smiljanic, Ranko Dobrota, Savko Prkacin, Ingrid Brkljacic, Neva Peros, Kristijan Tomic, Martina Lukinovic-Skudar, Vesna Basic Kes, Vanja Health Qual Life Outcomes Research BACKGROUND: Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes and can exist with or without neuropathic pain. We were interested in how neuropathic pain impairs the quality of life in diabetic patients and what is the role of comorbidities in this condition. METHODS: The study included 80 patients with painful DPN (group “P”) and 80 patients with DPN, but without neuropathic pain (group “D”). Visual analogue scale (VAS) and Leeds assessment of neuropathic symptoms and signs (LANSS) pain scale were used for assessment of neuropathic pain, SF-36 standardized questionnaire for assessment of the quality of life and BDI questionnaire for assessment of depression. RESULTS: Subjects in group P had statistically significantly lower values compared to group D in all 8 dimensions and both summary values of the SF-36 scale. We ascribe the extremely low results of all parameters of SF-36 scale in group P to painful diabetic polyneuropathy with its complications. The patients in group D showed higher average values in all dimension compared to group P, but also somewhat higher quality of life compared to general population of Croatia in 4 of 8 dimensions, namely vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH), which was unexpected result. Clinically, the most pronounced differences between two groups were noted in sleeping disorders and problems regarding micturition and defecation , which were significantly more expressed in group P. The similar situation was with walking distance and color-doppler sonography of carotid arteries, which were significantly worse in group P. Consequently, subjects in group P were more medicated than the patients in group D, particularly with tramadol, antiepileptics and antidepressants. CONCLUSION: Painful DPN is a major factor that influences various aspects of quality of life in diabetic patients. Additionally, this study gives an overview of diabetic population in the Republic of Croatia, information that could prove useful in future studies. BioMed Central 2014-12-03 /pmc/articles/PMC4264315/ /pubmed/25468384 http://dx.doi.org/10.1186/s12955-014-0171-7 Text en © Dermanovic Dobrota et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Dermanovic Dobrota, Vesna Hrabac, Pero Skegro, Dinko Smiljanic, Ranko Dobrota, Savko Prkacin, Ingrid Brkljacic, Neva Peros, Kristijan Tomic, Martina Lukinovic-Skudar, Vesna Basic Kes, Vanja The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title | The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title_full | The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title_fullStr | The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title_full_unstemmed | The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title_short | The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
title_sort | impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264315/ https://www.ncbi.nlm.nih.gov/pubmed/25468384 http://dx.doi.org/10.1186/s12955-014-0171-7 |
work_keys_str_mv | AT dermanovicdobrotavesna theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT hrabacpero theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT skegrodinko theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT smiljanicranko theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT dobrotasavko theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT prkaciningrid theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT brkljacicneva theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT peroskristijan theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT tomicmartina theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT lukinovicskudarvesna theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT basickesvanja theimpactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT dermanovicdobrotavesna impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT hrabacpero impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT skegrodinko impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT smiljanicranko impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT dobrotasavko impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT prkaciningrid impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT brkljacicneva impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT peroskristijan impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT tomicmartina impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT lukinovicskudarvesna impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes AT basickesvanja impactofneuropathicpainandothercomorbiditiesonthequalityoflifeinpatientswithdiabetes |